Drug Delivery Infusion System Market

The Global Drug Delivery Infusion System Market Market is valued at US$ 10,985.5Mn in 2019 and is expected to grow at a CAGR of 5.5% over the forecast period to reach a US$ YY Mn by 2027. Drug Delivery Infusion pump is a medical device, used to deliver fluids into a patient’s body in a controlled manner. Infusion pumps can deliver fluids in large or small amounts, and can be used to deliver of nutrients or medications, such as insulin or hormone related, antibiotics, chemotherapy drugs, and pain relievers etc., Increase in US market value for drug delivery infusion devices plays a vital role in the global market, due to expensive safety-enhancing pumping instruments and needleless technologies used in injection/infusion therapy. Robust and increased suppliers for  infusion pumps in the U.S. are:

CME America—products (distributed in the U.S. by B. Braun Melsungen) 

Hospira—products include the GemStar line of color-coded, compact, application-specific instruments

Moog—products (distributed in the U.S. by B. Braun Melsungen) include the Curlin 6000 CMS ambulatory infusion pump

Smiths Medical—products include the CADD line of infusion systems

WalkMed Infusion—products include the WalkMed line of infusion systems

Most of the major players have such increased supplies in Europe and Asia Pacific , boosting the global market for drug delivery infusion systems market

 

Market Dynamics

Drivers

• High prevalence of chronic diseases
• Increasing use of chemotherapy by Infusion System

Restraints

• Complications with infusion systems
• Increasing Infusion Pump error

High prevalence of chronic diseases

Chronic disease is responsible for 60% of all deaths worldwide. In Americans at least six in ten live with one of chronic disease, like heart disease, cancer, stroke, or diabetes. In 2017, 30.3 million US adults have diabetes. Diabetes is the seventh leading cause of death in the United States. Around 630,000 Americans die from heart disease each year. Coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015.  In 2017, an estimate of 86% of deaths and 77% of the disease burden in European region due to noncommunicable diseases. 

Increasing use of chemotherapy by Infusion System

chemotherapy is used for the treatment for cancer. The therapy involves the infusion of cytotoxic antineoplastic drugs and other medications directly into the bloodstream to inhibit the growth and spreading of cancer cells.  Infusion systems provide short-term access to the bloodstream. Physicians use these systems to deliver chemotherapeutic agents to individuals receiving chemotherapy once every few weeks. Integrated or closed catheters offer fully (360 degrees) encased needle tip protection and have a passive design to minimize needlestick injuries. These infusion systems have a closed system for managing the circulation of blood. They also provide safety benefits, such as reduction in medical errors and enhanced efficacy, for individuals undergoing chemotherapy. The launch of a new infusion pump for chemotherapy is driving the global drug delivery infusion system market.

In January 2018, Zoho Corporation funded vTitan Corporation to introduce its patented syringe infusion pumps. Accuflow SP-550 and Accuflow IBP-550 Syringe Infusion Pumps are available for patients undergoing chemotherapy, and heart surgery. The rising use of chemotherapy as a treatment option for cancer will lead to the demand for infusion systems for drug delivery.

Market Opportunities

Technological Advancements

The increase in technological advancement in the infusion pump is expected to boost the global drug delivery infusion system market. The increasing approval from regulatory bodies for including software to infusion pumps for better safety and comfort to patients. For instance, in May 2018, Baxter International Inc., a leader in innovative technology for medication delivery, received the FDA clearance for Spectrum IQ Infusion System with Dose IQ Safety Software. The Spectrum IQ system is the first-of-its-kind designed specifically for bi-directional electronic medical records (EMR) integration with new exclusive features to help ensure the correct medications and fluids are delivered to the patient. In June 2018, B. Braun Medical Inc., a leader in infusion therapy and pain management, received 510(k) clearance for the wireless 2nd generation software for its Perfusor Space Syringe Pump. This is the first syringe pump with air and road transport in the cleared indications for use.

In December 2016, IRADIMED CORPORATION, have Received FDA 510(k) clearance for its MRidium 3860+ MRI compatible IV infusion pump system, including its Dose Error Reduction System (DERS) software feature. The MRidium 3860+ MRI compatible IV infusion pump system provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com